Literature DB >> 11056418

The EGF receptor - an essential regulator of multiple epidermal functions.

M Jost1, C Kari, U Rodeck.   

Abstract

Epidermal keratinocytes express both the epidermal growth factor receptor (EGFR) and several of its ligands, establishing the constitutive elements of an autocrine loop in this cell type. Activation of the EGFR provides signals essential to several aspects of normal keratinocyte biology including cell cycle progression, differentiation, cell movement and cellular survival. It may be argued that enhanced keratinocyte survival via EGFR activation is the most important function as it limits the manifestation of other phenotypes. The frequent deregulation of EGFR expression and activation in benign and malignant hyperproliferative skin diseases motivates the investigation of EGFR-dependent intracellular pathways which contribute to the varied EGFR-dependent phenotypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056418

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  70 in total

1.  OPRM1 and EGFR contribute to skin pigmentation differences between Indigenous Americans and Europeans.

Authors:  Ellen E Quillen; Marc Bauchet; Abigail W Bigham; Miguel E Delgado-Burbano; Franz X Faust; Yann C Klimentidis; Xianyun Mao; Mark Stoneking; Mark D Shriver
Journal:  Hum Genet       Date:  2011-12-24       Impact factor: 4.132

2.  EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence.

Authors:  Azza Abdel-Aziz; Maha M Amin
Journal:  Diagn Pathol       Date:  2012-02-02       Impact factor: 2.644

Review 3.  Dermatologic adverse events to targeted therapies in lower GI cancers: clinical presentation and management.

Authors:  Viswanath Reddy Belum; Andrea Cercek; Virginia Sanz-Motilva; Mario E Lacouture
Journal:  Curr Treat Options Oncol       Date:  2013-09

4.  Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886).

Authors:  Yevgeniy Balagula; Katherine Barth Huston; Klaus J Busam; Mario E Lacouture; Paul B Chapman; Patricia L Myskowski
Journal:  Invest New Drugs       Date:  2010-10-27       Impact factor: 3.850

5.  Different patterns of toxicity after sequential administration of two anti-EGFR monoclonal antibodies.

Authors:  Miriam López-Gómez; César Gómez-Raposo; María Sereno; Francisco Zambrana; Enrique Casado
Journal:  Clin Transl Oncol       Date:  2010-11       Impact factor: 3.405

Review 6.  Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors:  Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal:  Adv Dermatol       Date:  2007

Review 7.  Molecular therapy in head and neck oncology.

Authors:  Jacques Bernier; Søren M Bentzen; Jan B Vermorken
Journal:  Nat Rev Clin Oncol       Date:  2009-05       Impact factor: 66.675

Review 8.  p53 and the pathogenesis of skin cancer.

Authors:  Cara L Benjamin; Honnavara N Ananthaswamy
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-15       Impact factor: 4.219

9.  Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7.

Authors:  V Rocher-Ros; S Marco; J-H Mao; S Gines; D Metzger; P Chambon; A Balmain; C A Saura
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

Review 10.  Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.